Fosamprenavir Expanded Access

• Status: Completed
• Trial end date: 2005-08-01

Summary

This open-label study will enable HIV-infected adults with limited treatment options to receive fosamprenavir until commercial supplies are available in Switzerland.

• Phase: Phase 4

Details

• Lead Sponsor: ViiV Healthcare
• Collaborator: GlaxoSmithKline
• Treatments: Fosamprenavir